Taiwanese Journal of Obstetrics and Gynecology
Volume 45, Issue 2 , Pages 100-106 , June 2006

Differential Expression of Growth-, Angiogenesis- and Invasion-Related Factors in The Development of Placenta Accreta

  • Jenn-Jhy Tseng

      Affiliations

    • Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, Taichung, Taiwan
    • Hung-Kuang University, Taichung, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Jenn-Jhy Tseng, Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, 160, Section 3, Taichung-Kang Road, Taichung 40705, Taiwan
    • ,
  • Min-Min Chou

      Affiliations

    • Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, Taichung, Taiwan
    • Hung-Kuang University, Taichung, Taiwan
    • Chung-Shan Medical University, Taichung, Taiwan

,Accepted 14 February 2006.

References 

  1. Chou MM , Ho ES , Lee YH . Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound . Ultrasound Obstet Gynecol . 2000;15:28–35
  2. Earl U , Bulmer JN , Briones A . Placenta accreta: an immunohistological study of trophoblast populations . Placenta . 1987;8:273–282
  3. Hochner-Celnikier D , Prus D , Matanes M , Yisraeli J , Yagel S , Goldman-Wohl D . Pathogenesis of placenta accreta is not related to over-invasiveness of the trophoblast . Am J Obstet Gynecol . 2004;191(Suppl 1):S88
  4. Ohlsson R . Growth factors, protooncogenes and human placental development . Cell Differ Dev . 1989;28:1–15
  5. Mühlhauser J , Crescimanno C , Kaufmann P , Höfler H , Zaccheo D , Castellucci M . Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R . J Histochem Cytochem . 1993;41:165–173
  6. Simon C, Frances A, Piguette GN, el Danasouri I, Zurawski G, Dang W, et al. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist . Endocrinology . 1994;134:521–528
  7. Graham CH , Lala PK . Mechanism of control of trophoblast invasion in situ . J Cell Physiol . 1991;148:228–234
  8. Aplin JD , Lacey H , Haigh T , Jones CJP , Chen CP , Westwood M . Growth factor-extracellular matrix synergy in the control of trophoblast invasion . Biochem Soc Trans . 2000;28:199–202
  9. Karmakar S , Das C . Regulation of trophoblast invasion by IL-1_ and TGF-_1 . Am J Reprod Immunol . 2002;48:210–219
  10. Pijnenborg R , Anthony J , Davey DA , Rees A , Tiltman A , Vercruysse L . Placental bed spiral arteries in the hypertensive disorders of pregnancy . Br J Obstet Gynaecol . 1991;98:648–655
  11. Bjercke S . Normal implantation is important in order to avoid pregnancy complications and diseases later in life . Tidsskr Nor Laegeforen . 1999;119:3903–3908
  12. Genbacev O , Joslin P , Damsky CH , Polliotti BM , Fisher SJ . Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia . J Clin Invertebr . 1996;97:540–550
  13. Strickland S , Richards WG . Invasion of the trophoblasts . Cell . 1992;71:355–357
  14. Fisher SJ , Zhou Y , Huang L , Winn VD . When is seeing believing? The use of color Doppler ultrasound to diagnose placenta accreta in the first trimester of pregnancy . Ultrasound Obstet Gynecol . 2002;19:540–542
  15. Gallery ED , Campbell S , Ilkovski B , Sinosich MJ , Jackson C . A novel in vitro co-culture system for the study of maternal decidual endothelial cell-trophoblast interactions in human pregnancy . Br J Obstet Gynaecol . 2001;108:651–653
  16. Tseng JJ , Hsu SL , Wen MC , Ho ES , Chou MM . Expression of epidermal growth factor receptor and c-erbB-2 oncoprotein in trophoblast populations of placenta accreta . Am J Obstet Gynecol . 2004;191:2106–2113
  17. Vuorela P , Hatva E , Lymboussaki A , et al.   Expression of vascular endothelial growth factor and placenta growth factor in human placenta . Biol Reprod . 1997;56:489–494
  18. Ahmed A , Li XF , Dunk C , Whittle MJ , Rushton DI , Rollason T . Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta . Growth Factors . 1995;12:235–243
  19. Khaliq A , Li XF , Shams M , et al.   Localisation of placenta growth factor (PlGF) in human term placenta . Growth Factors . 1996;13:243–250
  20. Clark DE , Smith SK , Licence D , Evans AL , Charnock-Jones DS . Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation . J Endocrinol . 1998;159:459–467
  21. Kumazaki K , Nakayama M , Suehara N , Wada Y . Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathological conditions . Hum Pathol . 2002;33:1069–1077
  22. de Vries C , Escobedo J , Ueno H , Houck K , Ferrara N , Williams LT . The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor . Science . 1992;255:989–991
  23. Terman BI, Dougher-Vermazen M, Carrion M, Dimitrov D, Armellino DC, Gospodarowicz D, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor . Biochem Biophys Res Commun . 1992;187:1579–1586
  24. Millauer B , Shawver LK , Plate KH , Risau W , Ullrich A . Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant . Nature . 1994;367:576–579
  25. Joukov V , Pajusola K , Kaipainen A , et al.   A novel vascular endothelial growth factor, VEGF-C, is the ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases . EMBO J . 1996;15:290–298
  26. Enholm B , Jussila L , Karkkainen M , Alitano K . Vascular endothelial growth factor C: a growth factor for lymphatic and blood vascular endothelial cells . Trends Cardiovasc Med . 1998;8:292–297
  27. Talamentes A , Ogren L . The placenta as an endocrine organ: polypeptides . In:  Knobil E ,  Neill J editor. The Physiology of Reproduction . New York: Raven Press; 1988;p. 2093–2144
  28. Chaiworapongsa T , Romero R , Espinoza J , et al.   Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia . Am J Obstet Gynecol . 2004;190:1541–1550
  29. Ebos JM , Bocci G , Man S , et al.   A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma . Mol Cancer Res . 2004;2:315–326
  30. Vuorela P , Carpén O , Tulppala M , Halmesmäki E . VEGF, its receptors and the Tie receptors in recurrent miscarriage . Mol Hum Reprod . 2000;6:276–282
  31. Helske S , Vuorela P , Carpén O , Hornig C , Weich H , Halmesmäki E . Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies . Mol Hum Reprod . 2001;7:205–210
  32. Hornig C , Barleon B , Ahmad S , Vuorela P , Ahmed A , Weich HA . Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids . Lab Invest . 2000;80:443–454
  33. Tseng JJ , Chou MM , Hsieh YT , Wen MC , Ho ES , Hsu SL . Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta . Placenta . 2006;27:70–78
  34. Dunk C , Ahmed A . Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast . Histol Histopathol . 2001;16:359–375
  35. Cross MJ , Dixelius J , Matsumoto T , Claesson-Welsh L . VEGF-receptor signal transduction . Trends Biochem Sci . 2003;28:488–494
  36. Islami D , Mock P , Bischof P . Effects of human chorionic gonadotropin on trophoblast invasion . Semin Reprod Med . 2001;19:49–53
  37. Zygmunt M , Herr F , Keller-Schoenwetter S , Kunzi-Rapp K , Munstedt K , Rao CV . Characterization of human chorionic gonadotropin as a novel angiogenic factor . J Clin Endocrinol Metab . 2002;87:5290–5296
  38. Corbacho AM , Martinez De La Escalera G , Clapp C . Roles of prolactin and related members of the prolactin/ growth hormone/placental lactogen family in angiogenesis . J Endocrinol . 2002;173:219–238
  39. Maynard SE , Min JY , Merchan J , et al.   Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia . J Clin Invest . 2003;111:649–658
  40. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria . J Biol Chem . 2003;278:12605–12608
  41. Kuo B , Li Y , Zhang L , et al.   In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragment . Exp Mol Pathol . 2004;76:129–137
  42. Felmeden DC , Blann AD , Lip GYH . Angiogenesis: basic pathophysiology and implications for disease . Eur Heart J . 2003;24:586–603
  43. Partanen J , Dumont D . Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development . In:  Claesson-Welsh L editors. Vascular Growth Factors and Angiogenesis . Berlin: Springer-Verlag; 1999;p. 159–172
  44. Lin WC , Li AF , Chi CW , Chung WW , Huang CL , Lui WY . Tie-1 protein tyrosine kinase: a novel independent prognostic marker for gastric cancer . Clin Cancer Res . 1999;5:1745–1751
  45. Currie MJ , Gunningham SP , Han C , Scott PA , Robinson BA , Harris AL . Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling . Clin Cancer Res . 2001;7:918–927
  46. Wulff C , Wilson H , Dickson SE , Wiegand SJ , Fraser HM . Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy . Biol Reprod . 2002;66:802–812
  47. Regnault TR , Galan HL , Parker TA , Anthony RV . Placental development in normal and compromised pregnancies-a review . Placenta . 2002;23(Suppl A):S119–S129
  48. Torry DS , Ahn H , Barnes EL , Torry RJ . Placenta growth factor: potential role in pregnancy . Am J Reprod Immunol . 1999;41:79–85
  49. Wulff C , Weigand M , Kreienberg R , Fraser HM . Angiogenesis during primate placentation in health and disease . Reproduction . 2003;126:569–577
  50. Tseng JJ , Hsu SL , Ho ES , Hsieh YT , Wen MC , Chou MM . Differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors in placentas from pregnancies complicated by placenta accreta . Am J Obstet Gynecol . 2006;194:564–571
  51. Dunk C , Shams M , Nijjar S , Rhaman M , Qiu Y , Bussolati B . Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development . Am J Pathol . 2000;156:2185–2199
  52. Rowe AJ , Wulff C , Fraser HM . Localization of mRNA for vascular endothelial growth factor (VEGF), angiopoietins and their receptors during the periimplantation period and early pregnancy in marmosets (Callithrix jacchus) . Reproduction . 2003;126:227–238
  53. Teichert-Kuliszewska K , Maisonpierre PC , Jones N , Campbell AI , Master Z , Bendeck MP . Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie-2 . Cardiovasc Res . 2001;49:659–670
  54. Asahara T , Chen D , Takahashi T , Fujikawa K , Keamey M , Magner M . Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization . Circ Res . 1998;83:233–240
  55. Chong AY , Caine GJ , Freestone B , Blann AD , Lip GY . Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor Tie-2 levels in congestive heart failure . J Am Coll Cardiol . 2004;43:423–428
  56. Matsunaga T , Warltier DC , Tessmer J , Weihrauch D , Simons M , Chilian WM . Expression of VEGF, angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis . Am J Physiol Heart Circ Physiol . 2003;285:H352–H358
  57. Nakayama T , Hatachi G , Wen CY , Yoshizaki A , Yamazumi K , Niino D . Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: immunohistochemical analysis and correlation with clinicopathological factors . World J Gastroenterol . 2005;11:964–969
  58. Oka N , Yamamoto Y , Takahashi M , Nishitani M , Kanayama HO , Kawaga S . Expression of angiopoietin-1 and -2, and its clinical significance in human bladder cancer . BJU Int . 2005;95:660–663
  59. Oliner J , Min H , Leal J , Yu D , Rao S , You E . Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2 . Cancer Cell . 2004;6:507–516
  60. Durkin AJ , Bloomston M , Yeatman TJ , Gilbert-Barness E , Cojita D , Rosemurgy AS . Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors . J Am Coll Surg . 2004;199:724–731
  61. Hurskainen T, Seiki M, Apte SS, Syrjäkallio-Ylitalo M, Sorsa T, Oikarinen A, et al. Production of membrane-type matrix metalloproteinase-1 (MT-MMP-1) in early human placenta: a possible role in placental implantation? . J Histochem Cytochem . 1998;46:221–229
  62. Huppertz B , Kerschanska S , Demir AY , Frank HG , Kaufmann P . Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta . Cell Tissue Res . 1998;291:133–148
  63. Librach CL , Werb Z , Fitzgerald ML , et al.   92-kD type IV collagenase mediates invasion of human cytotrophoblasts . J Cell Biol . 1991;113:437–449
  64. Hanemaaijer R , Koolwijk P , Clercq LL , de Vree WJA , van Hinsbergh VWM . Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells . Biochem J . 1993;296:803–809
  65. Sato H , Takino T , Okada Y . A matrix metalloproteinase expressed on the surface of invasive tumor cells . Nature . 1994;370:61–65
  66. Leber T , Boyd R , Balkwill F . Tumour cell-stromal cell interactions: proteases and protease inhibitors . In:  Sharp F ,  Blackett T ,  Berek J ,  Bast R editor. Ovarian Cancer 5 . Oxford: Isis Medical Media Ltd; 1998;p. 121–129
  67. Aplin JD . Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro . J Cell Sci . 1991;99:681–692
  68. Morgan M , Kniss D , McDonnell S . Expression of metalloproteinases and their inhibitors in human trophoblast continuous cell lines . Exp Cell Res . 1998;242:18–26
  69. Bjorn SF , Hastrup N , Lund LR , Dano K , Larsen JF , Pyke C . Coordinated expression of MMP-2 and its putative activator, MT1-MMP, in human placentation . Mol Hum Reprod . 1997;3:713–723
  70. Bjorn SF , Hastrup N , Larsen JL , Lund LR , Pyke C . Messenger RNA for membrane type 2 matrix metalloproteinases MT2- MMP is expressed in human placenta of first trimester . Placenta . 2000;21:170–176
  71. Cao J , Sato H , Takino T , Seiki M . The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation . J Biol Chem . 1995;270:801–805
  72. Nawrocki B , Polette M , Marchand V , et al.   Membrane-type matrix metalloproteinase-1 expression at the site of human placentation . Placenta . 1996;17:565–572
  73. Denhardt DT , Feng B , Edwards DR . Tissue inhibitor of metalloproteinases: structure, control of expression and biological functions . Pharmacol Ther . 1993;59:329–341
  74. Murray GI , Duncan ME , Arbucle E , Melvin WT , Fothergill JE . Matrix metalloproteinases and their inhibitors in gastric cancer . Gut . 1998;43:791–797
  75. Polette M , Nawrocki B , Pintiaux A , et al.   Expression of gelatinases A and B and their tissue inhibitors by cells of early and term placenta and gestational endometrium . Lab Invest . 1994;71:838–846
  76. Ruck P , Marzusch K , Horny HP , Dietl J , Kaiserling E . Distribution of tissue inhibitor of metalloproteinases-2 (TIMP-2) in trophoblasts of early human pregnancy . Placenta . 1995;16:A62
  77. Ruck P , Marzusch K , Horny HP , Dietl J , Kaiserling E . The distribution of tissue inhibitor of metalloproteinases-2 (TIMP-2) in the human placenta . Placenta . 1996;17:263–266
  78. Van Meter TE , Broaddus WC , Rooprai HK , Pilkington GJ , Fillmore HL . Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas . Neuro-oncol . 2004;6:188–199
  79. Munaut C , Noel A , Hougrand O , Foidart JM , Boniver J , Deprez M . Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas . Int J Cancer . 2003;106:848–855
  80. Sounni NE , Roghi C , Chabottaux V , et al.   Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases . J Biol Chem . 2004;279:13564–13574
  81. Guo P , Imanishi Y , Cackowski FC , et al.   Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma . Am J Pathol . 2005;166:877–890

PII: S1028-4559(09)60205-9

doi: 10.1016/S1028-4559(09)60205-9

Taiwanese Journal of Obstetrics and Gynecology
Volume 45, Issue 2 , Pages 100-106 , June 2006

Article Tools